Results 111 to 120 of about 25,651 (184)

Modified submammary implantable cardioverter-defibrillator implantation after extravascular implantable cardioverter-defibrillator P-wave oversensing in a patient with desmoplakin-related cardiomyopathy. [PDF]

HeartRhythm Case Rep
Burright I, Giudicessi J, Berberoglu I, Gates-Tanzer L, Sharaf B, Sugrue A.   +5 more
europepmc   +1 more source

Long‐Term Follow‐Up After Atrioventricular Node Ablation in Patients With Atrial Fibrillation: A Nationwide Danish Cohort Study

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 606-613, March 2026.
ABSTRACT Introduction Atrioventricular node (AVN) ablation after pacemaker implantation is a rate control option for patients with symptomatic atrial fibrillation (AF) when rhythm control with anti‐arrhythmic drug therapy and/or ablation with pulmonary vein isolation fails.
Anders Fyhn Elgaard, Jacob Moesgaard Larsen, Pia Thisted Dinesen, Sam Riahi, Søren Lundbye‐Christensen, Peter Karl Jacobsen, Arne Johannessen, Uffe Jakob Ortved Gang, Steen Buus Kristiansen, Stig Djurhuus, Gregory Y. H. Lip   +10 more
wiley   +1 more source

Is Septal Pacing Effective for Antitachycardia Pacing of Implantable Cardioverter-Defibrillator? [PDF]

JACC Asia
Ishibashi K, Ueda N, Kusano K.
europepmc   +1 more source

Antimicrobial Envelopes for Cardiac Device Infection Prevention: A Meta‐Analysis of Randomized and Matched Studies

Pacing and Clinical Electrophysiology, Volume 49, Issue 3, Page 279-286, March 2026.
ABSTRACT Introduction Cardiac implantable electronic device (CIED)‐associated infections are a significant procedural complication. Antibacterial envelopes have emerged as a potential strategy to mitigate this risk, though the evidence regarding their prognostic benefit remains inconclusive.
Alonzo Armani Prata, Luís Fernando Ferreira Cavalcante, Gabriela Blanco Stutz, Thalia Melamed, Caio Rezende Lima, Andrew H. Locke, Alexandra Régia Dantas Brígido   +6 more
wiley   +1 more source

Initial experience with the extravascular implantable cardioverter-defibrillator in pediatric patients. [PDF]

Heart Rhythm O2
Walsh M, Ryan C, Prendiville T, Casey F, McCrossan B, McMahon C, Walsh KP.   +6 more
europepmc   +1 more source

Efficacy and Safety of the Sync‐AV II Temporary Cardiac Pacing Catheter (EASY II Trial)

Pacing and Clinical Electrophysiology, Volume 49, Issue 3, Page 257-266, March 2026.
ABSTRACT Background Cardiac pacing is crucial for patients with hemodynamically unstable bradyarrhythmias. For most indications, transvenous pacemakers are used to pace the right ventricle, causing atrioventricular dyssynchrony, which may lead to significant hemodynamic compromise.
Som A. Bailey, Bertrand Ebner, Christian Marin y Kall, Jeffrey J. Goldberger, Santiago Gallo, Eduardo J. de Marchena   +5 more
wiley   +1 more source

Sexual health in patients with an implantable cardioverter-defibrillator: A narrative review. [PDF]

Heart Rhythm O2
Poels P, Stuyck N, Dorrestijn A, Robyns T, Moons P, Willems R, Vandenberk B.   +6 more
europepmc   +1 more source

Initial UK Experience of Focal Pulsed Field Ablation

Pacing and Clinical Electrophysiology, Volume 49, Issue 3, Page 233-239, March 2026.
ABSTRACT Background Pulsed field ablation (PFA) offers potential safety and efficacy advantages for catheter ablation. Delivering this energy source using pre‐existing contact force sensing catheters and mapping systems is attractive due to familiarity and accessibility.
Waqas Ullah, Daniel Raine, Maciej Debski, Shi Rui, Vasanth Sritharan, Wissam Ahmed, Arthur Yue, Tom Wong, Moloy Das   +8 more
wiley   +1 more source

Tips and tricks for extravascular implantable cardioverter-defibrillator implantation: a single-centre experience. [PDF]

Europace
Biffi M, Quaranta A, Martignani C, Diemberger I, Angeletti A, Verde C, Frisoni J, Izzo AN, Spadotto A, Ziacchi M.   +9 more
europepmc   +1 more source

Safety Outcomes of Hybrid Open Chest Transvenous Lead Extraction: A Multicenter Experience

Pacing and Clinical Electrophysiology, Volume 49, Issue 3, Page 247-256, March 2026.
ABSTRACT Background Hybrid open chest transvenous lead extraction (TLE), combining surgical and endovascular techniques, may be utilized in patients requiring concomitant cardiac surgery or with high‐risk features for endovascular extraction. Outcome data in this population remains sparse. Aims To evaluate procedural outcomes and identify predictors of
Nadeev Wijesuriya, Helena Lytton Cobbold, Keisha Kellman, Nikolaos Vogiatzakis, Felicity De Vere, Sandra Howell, Alphonsus Liew, Jonathan M. Behar, Paolo Bosco, Gianluca Lucchese, Vias Markides, Neil R. Grubb, Vishal Mehta, Steven A. Niederer, Tom Wong, Christopher A. Rinaldi   +15 more
wiley   +1 more source